Generic Name and Formulations:
Hydroquinone 4%; crm; contains sulfites.
Indications for LUSTRA:
UV-induced skin dyschromia and discoloration due to hormonal changes or skin trauma.
Apply to affected areas twice daily. Discontinue if lightening effect does not occur after 2 months.
Do skin sensitivity test before use; do not use if itching, vesicle formation or excessive inflammation occurs. Avoid sun and UV light. Not for use as a sunscreen. Avoid eyes. Pregnancy (Cat.C). Nursing mothers.
Clinical Pain Advisor Articles
- Opioids: Clinician Concern and Prescribing Practices
- Quantity of Opioids Prescribed Linked to Higher Patient-Reported Consumption
- Ensuring Safety During Long-Term Opioid Therapy
- Screening for Hyperglycemia Prior to Steroid Injections for Chronic Pain
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- Intervention by Pharmacists May Effectively Reduce Use of Inappropriate Medications in the Elderly
- Tips Provided for Budgeting in Medical Residency
- Give Thanks: The Role of Gratitude in Combating Burnout
- Persistent Back Pain Linked to Earlier Mortality in Older Women
- Cannabinoids May Be Effective on Experimental Pain Threshold and Tolerance, Not Intensity
- PainDETECT May Not Be Optimal to Detect Neuropathic Components of Orofacial Pain